Special considerations for different GLP-1 medications While the general principles of fiber supplementation apply across all GLP-1 receptor agonists, there are nuances worth noting for specific medications
Overall, 140 participants (32.1%) reported lifetime use of semaglutide, tirzepatide, dulaglutide, liraglutide, or exenatide, used for either diabetes management or weight loss, while 96 (22%) reported current use
In the AMY study, bothersome hot flushes rose from 8.8% before menopause to 37.3% in late perimenopause the same years many people are on a GLP-1
It can be a valuable addition for anyone looking to enhance their weight management efforts or support their system while taking GLP-1/GIP receptor agonists
Prevention strategies targeting these mechanisms substantially reduce risk
Working with a specialized supplier makes that progression much easier